Equities

Spectral AI Inc

MDAI:NAQ

Spectral AI Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)1.19
  • Today's Change0.05 / 4.39%
  • Shares traded595.69k
  • 1 Year change-52.02%
  • Beta0.4074
Data delayed at least 15 minutes, as of Nov 22 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 17-Oct-24
  • 14-Nov-24
  • 21-Nov-24
Select bar for recommendation details.
Recommendations21-Nov-24
Buy1
Outperform3
Hold0
Sell0
Strong Sell0

Share price forecast in USD

The 5 analysts offering 12 month price targets for Spectral AI Inc have a median target of 5.00, with a high estimate of 10.50 and a low estimate of 3.00. The median estimate represents a 338.60% increase from the last price of 1.14.
High821.1%10.50
Med338.6%5.00
Low163.2%3.00

Earnings history & estimates in USD

On Nov 06, 2024, Spectral AI Inc reported 3rd quarter 2024 losses of -0.08 per share.
The next earnings announcement is expected on Mar 25, 2025.
Average growth rate+26.48%
Spectral AI Inc reported annual 2023 losses of -1.48 per share on Mar 29, 2024.
More ▼

Revenue history & estimates in USD

Spectral AI Inc had 3rd quarter 2024 revenues of 8.17m. This bettered the 7.15m consensus of the 4 analysts covering the company. This was 54.59% above the prior year's 3rd quarter results.
Average growth rate+15.72%
Spectral AI Inc had revenues for the full year 2023 of 18.06m. Last year the company did not report any revenues.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.